GemcitabineThrombotic microangiopathy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1658卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32409-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：212 / 212

相关论文

共 50 条

[41] AntineoplasticsThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2020, 1813 (1) : 38 - 38
[42] AtezolizumabThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 66 - 66
[43] TacrolimusThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2015, 1566 (1) : 213 - 213
[44] CarfilzomibThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2021, 1862 (1) : 120 - 120
[45] Eculizumab/GemcitabineThrombotic microangiopathy and lack of efficacy
Reactions Weekly, 2024, 1998 (1) : 206 - 206
[46] GemcitabineThrombotic microangiopathy, lupus nephritis and acute interstitial nephritis: case report
Reactions Weekly, 2019, 1752 (1) : 177 - 177
[47] Immune globulinThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2014, 1499 (1) : 17 - 17
[48] Multiple drugsThrombotic microangiopathy: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 272 - 272
[49] GemcitabineNecrotic thrombotic microangiopathy: 2 case reports
Reactions Weekly, 2017, 1638 (1) : 103 - 103
[50] CarfilzomibThrombotic-microangiopathy: 2 case reports
Reactions Weekly, 2024, 2032 (1) : 117 - 117

← 1 2 3 4 5 →